Elsa Hansen

Publication Activity (10 Years)

Years Active: 2020-2021
Publications (10 Years): 6

Top Topics

Acinetobacter Baumannii

Multidrug Resistant

Top Venues

Evolutionary applications

BioEssays : news and reviews in molecular, cellular and developmental biology

This page only lists publications with an associated author ORCID identifier.

Publications

Antoine M Dujon, Athena Aktipis, Catherine Alix-Panabières, Sarah R Amend, Amy M Boddy, Joel S Brown, Jean-Pascal Capp, James DeGregori, Paul Ewald, Robert A Gatenby, Marco Gerlinger, Mathieu Giraudeau, Rodrigo K Hamede, Elsa Hansen, Irina Kareva, Carlo C Maley, Andriy Marusyk, Nicholas McGranahan, Michael J Metzger, Aurora M Nedelcu, Robert John Noble, Leonard Nunney, Kenneth J Pienta, Kornelia Polyak, Pascal Pujol, Andrew F Read, Benjamin Roche, Susanne Sebens, Eric Solary, Kateřina Staňková, Holly Swain Ewald, Frederic Thomas, Beata Ujvari
Identifying key questions in the ecology and evolution of cancer. Evolutionary applications 14 (4) (2021)
Clare L Kinnear, Elsa Hansen, Valerie J Morley, Kevin C Tracy, Meghan Forstchen, Andrew F Read, Robert J Woods
Daptomycin treatment impacts resistance in off-target populations of vancomycin-resistant Enterococcus faecium. PLoS biology 18 (12) (2020)
Elsa Hansen, Jason Karslake, Robert J Woods, Andrew F Read, Kevin B Wood
Antibiotics can be used to contain drug-resistant bacteria by maintaining sufficiently large sensitive populations. PLoS biology 18 (5) (2020)
Alita R Burmeister, Elsa Hansen, Jessica J Cunningham, E Hesper Rego, Paul E Turner, Joshua S Weitz, Michael E Hochberg
Fighting microbial pathogens by integrating host ecosystem interactions and evolution. BioEssays : news and reviews in molecular, cellular and developmental biology 43 (3) (2020)
Elsa Hansen, Andrew F Read
Cancer therapy: Attempt cure or manage drug resistance? Evolutionary applications 13 (7) (2020)
Elsa Hansen, Andrew F Read
Modifying Adaptive Therapy to Enhance Competitive Suppression. Cancers 12 (12) (2020)